GALMED PHARMACEUTICALS LTD. Proceeds from Common Stock Issued
GALMED PHARMACEUTICALS LTD. (GLMD) reported Proceeds from Common Stock Issued of $1.20 million for the 6-month period ending 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-09-02
- GALMED PHARMACEUTICALS LTD. proceeds from issuance of common stock for the quarter ending 2025-12-31 was $7.50M.
- GALMED PHARMACEUTICALS LTD. proceeds from issuance of common stock for the quarter ending 2025-09-30 was $99.00K.
- GALMED PHARMACEUTICALS LTD. proceeds from issuance of common stock for the quarter ending 2024-12-31 was -$14.00K.
| Period end | Proceeds from Issuance of Common Stock 0 month | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock as first filed | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 6 month as first filed | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.20M 6-K · filed 2026-09-02 | |||||||||
| 2025-12-31 | $7.50M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | $7.59M derived: sum of 2 quarters · filed 2026-03-31 | $7.67M 20-F · filed 2026-03-31 | |||||||
| 2025-09-30 | $99.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | $174.00K 6-K · filed 2025-11-26 | ||||||||
| 2025-06-30 | $75.00K 6-K · filed 2026-09-02 | |||||||||
| 2024-12-31 | -$14.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-04-02 | $4.39M 20-F · filed 2025-04-02 | ||||||||
| 2024-09-30 | $4.40M 20-F · filed 2026-03-31 | $4.40M 6-K · filed 2025-11-26 | ||||||||
| 2023-07-18 | $6.20M 6-K · filed 2025-11-26 | $4.40M 20-F · filed 2025-04-02 | $6.20M 20-F · filed 2024-04-04 | |||||||
| 2021-12-31 | $9.22M 20-F · filed 2024-04-04 | |||||||||
| 2020-12-31 | $707.00K 20-F · filed 2023-03-29 | |||||||||
| 2018-06-30 | $79.16M 6-K · filed 2018-08-02 | |||||||||
| 2017-12-31 | $15.02M 20-F · filed 2018-03-13 | |||||||||
| 2017-08-31 | $2.70M 20-F · filed 2019-03-13 | |||||||||
| 2017-06-30 | $0.00 6-K · filed 2018-08-02 | $247.00K 6-K · filed 2017-07-31 | ||||||||
| 2016-12-31 | $4.48M 20-F · filed 2018-03-13 | $0.00 20-F · filed 2017-03-23 | ||||||||
| 2016-06-30 | $11.00K 6-K · filed 2017-07-31 | |||||||||
| 2015-12-31 | $0.00 20-F · filed 2018-03-13 | |||||||||
| 2015-06-30 | $0.00 6-K · filed 2017-06-23 | |||||||||
| 2014-12-31 | $2.00M 20-F · filed 2017-03-23 | |||||||||
| 2013-12-31 | $120.00K 20-F · filed 2016-03-22 | |||||||||
| 2012-12-31 | $0.00 20-F · filed 2015-03-31 |